profile icon
Dr

Robert Campbell

Honorary
Rural Health
life sciences & biomedicine
science & technology
open-label
chronic lymphocytic-leukemia
osimertinib
general & internal medicine
medicine, general & internal
bruton's tyrosine kinase
bruton’s tyrosine kinase
Robert Campbell's Profile Picture
Dr

Robert Campbell

 
Division
Medicine, Dentistry and Health Sciences
Robert Campbell's Profile Picture
Dr

Robert Campbell

 
Print
Robert's  Short Profile
 

Find out more about Robert Campbell's experience

Robert Campbell's highlights

Scholarly Works

Displaying the 2 most recent scholarly works by Robert Campbell.

Scholarly works icon

Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance

Joshua WD Tobin, Gabrielle Rule, Katherine Colvin, Lourdes Calvente, David Hodgson, Stephen Bell, Chengetai Dunduru, James Gallo, Erica S Tsang, Xuan Tan, Jonathan Wong, Jessica Pearce, Robert Campbell, Shao Tneh, Sophie Shorten, Melissa Ng, Tara Cochrane, Constantine S Tam, Emad Abro, Eliza Hawkes, et al.

Journal article  |  2019  |  Blood Advances

Management practices in early-stage (I/II) follicular lymphoma (FL) are variable and include radiation (RT), systemic therapy, or ..

Scholarly works icon

Novel Indications for Bruton's Tyrosine Kinase Inhibitors, beyond Hematological Malignancies

Robert Campbell, Geoffrey Chong, Eliza A Hawkes

Journal article  |  2018  |  Journal of Clinical Medicine

2

Scholarly Works

Keyword Analysis

Clinical Health (organs, Diseases and Abnormal Conditions)
Oncology and Carcinogenesis
Expanding Knowledge
Medical Biochemistry and Metabolomics

Credentials

Positions

Honorary

Rural Health